Valley Wealth Managers’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-250
Closed -$31K 393
2022
Q3
$31K Buy
+250
New +$32.9K ﹤0.01% 265
2021
Q2
Sell
-25,100
Closed -$3.22M 203
2021
Q1
$3.22M Buy
25,100
+3,183
+15% +$392K 0.29% 79
2020
Q4
$2.61M Sell
21,917
-680
-3% -$82.9K 0.26% 81
2020
Q3
$2.59M Sell
22,597
-503
-2% -$59.4K 0.28% 64
2020
Q2
$2.63M Sell
23,100
-1,628
-7% -$173K 0.3% 68
2020
Q1
$1.99M Sell
24,728
-202
-0.8% -$20.9K 0.26% 77
2019
Q4
$2.66M Buy
24,930
+3,250
+15% +$339K 0.27% 73
2019
Q3
$2.32M Sell
21,680
-900
-4% -$92.4K 0.25% 74
2019
Q2
$2.3M Sell
22,580
-50
-0.2% -$4.8K 0.24% 71
2019
Q1
$2.04M Buy
+22,630
New +$1.96M 0.22% 73

Other funds holding DGX

Valley Wealth Managers's DGX Position: Q4 2022 in Review

Valley Wealth Managers sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 250 shares — an estimated $31K sold.

Valley Wealth Managers first reported a position in DGX in Q1 2019 and held it in 10 quarters. The position peaked at $3.22M in Q1 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Valley Wealth Managers reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Valley Wealth Managers sold 250 Quest Diagnostics shares in Q4 2022, an estimated $31K.
  • Valley Wealth Managers first reported a position in Quest Diagnostics in Q1 2019 and held it in 10 quarters.
  • Valley Wealth Managers's Quest Diagnostics position peaked at $3.22M in Q1 2021.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Valley Wealth Managers's 13F filing for Q4 2022, filed 1 Feb 2023.